期刊文献+

薄层液基细胞学检测3500例结果及临床分析

Clinical Analysis of Thinprep Liquid Based Cytology Test in 3500 Cases of Cervical Lesions
下载PDF
导出
摘要 目的应用薄层液基细胞学技术及TBS诊断系统,探讨宫颈癌及癌前病变的相关因素及临床细胞学特点。方法对3 500例受检者的宫颈脱落细胞采用薄层液基细胞学(TCT)检测和TBS分类诊断,将不典型鳞状上皮细胞(ASCUS)以上病变列为细胞学阳性病例,分析不同宫颈病变及其与临床的关系。结果 3 500例受检者TCT标本满意率为97.36%,细胞学阳性病例447例,总检出率12.77%,其中ASCUS+不典型腺上皮细胞(AGUS)占6.40%;低度鳞状上皮内病变(LSIL)占2.94%;高度鳞状上皮内病变(HSIL)占3.26%;鳞状细胞癌和腺癌(CA)占0.17%;人乳头瘤病毒(HPV)感染348例(9.94%)。在447例TCT阳性病例中,宫颈光滑-轻糜组与中-重糜组分别占50.11%和49.89%。结论 TCT和TBS系统能准确反映宫颈病变情况,HPV是宫颈上皮内瘤样病变(CIN)的重要相关因素,预防HPV感染、筛查和监测HPV感染对象、治疗HPV,及阻止CIN病变是防止宫颈癌的关键。 Objective To study clinical cytological features and relevent factors of cervical carcinoma and precancerous lesions by TCT and The Besthesda System(TBS).Methods 3 500 cases were examined by TCT and TBS,then the clinical relativity of different cervical lesions was analyzed.Results The satisfactory rate of TCT samples was 97.36%.In the 3 500 cases,the positive rate of TCT cytology was 12.77%(447/3 500) and 348 cases(9.94%) were HPV infected.In the 447 positive cases,6.40% were ASCUS and AGUS,2.94% were LSIL,3.26% were HSIL and 0.17% were CA;the rate of the smooth-slight erosion group and that of the moderate-severe erosion group were 50.11% and 49.89% respectively.Conclusion TCT and TBS might accurately reflect the condition of cervical lesions.Incidence of HPV infection is the important correlative factor of CIN(cervical intraepithelial neop-lasia).Prevention from the infection of HPV,efficient screening and surveying of HPV infection,curing and blocking the development of CIN are key points for prevention of cervical carcinoma.
出处 《黑龙江医学》 2010年第9期666-667,683,共3页 Heilongjiang Medical Journal
基金 黑龙江省科技厅攻关项目(No.GB05C402-11)
关键词 TBS诊断系统 宫颈病变 细胞学 TBS Cervical lesions Cytology
  • 相关文献

参考文献4

二级参考文献21

  • 1Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence[J]. Gastroenterology, 2003, 124: 544-560.
  • 2Sulik SM, Kroeger K, Schultz JK, et al. Are fluid-based cytologies superior to the conventional papanicolaou test? a systematic review. J Fam Pract, 2001,50(12):1040-1046.
  • 3Ries L, Kosary C, Hanky B, et al. SEER cancer statistics review,1973~1995. Bethesda,MD:National Cancer Institute, 1998.
  • 4Hutchinson ML, Cassin CM, Ball HG. The efficacy of an automated preparation device for cervical cytology. Am J Clin Pathol, 1991,96(3):300-305.
  • 5Sprenger E, Schwarzmann P, Kirkpatrick M, et al. The false negative rate in cervical cytology. Acta Cytol, 1996,40(1):81-89.
  • 6Pajtler M, Audy-Jurkovic S. Pap smear adequacy-is the assessing criterion induding endocervical cells really valid? Coll Antropol, 2002,26(2):565-570.
  • 7Cheung AN, Szeto EF, Leung BS, et al. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population. Cancer,2003,99(6):331-335.
  • 8Abulafia O, Pezzullo JC, Sherer DM. Performance of ThinPrep liquidbased cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quant itative survey. Gynecol Oncol, 2003,90(1):137-144.
  • 9Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening. Cancer, 1999,87(2):48-55.
  • 10Maxwell GL, Carlson JW, Ochoa M, et al. Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. Obstet Gynocol, 2002,100(4):740-748.

共引文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部